Belantamab mafodotin

Blenrep 70 mg poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 23 Jul 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

BlenrepEuropean UnionAuthorised

BlenrepBrazil · Glaxosmithkline Brasil LtdaSame brand
BlenrepCanada · 70 MG / VIAL · Powder For Solution · Glaxosmithkline INCSame brand
BlenrepCanada · 100 MG / VIAL · Powder For Solution · Glaxosmithkline INCSame brand
Blenrep 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 110 mg · polvo para concentrado para solución para perfusión · Glaxosmithkline Trading Services LimitedSame brand
Blenrep 70 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 77 mg · polvo para concentrado para solución para perfusión · Glaxosmithkline Trading Services LimitedSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Belantamab mafodotin

Blenrep 70 mg poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 23 Jul 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

BlenrepEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Blenrep 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 100 mg · polvo para concentrado para solución para perfusión · Glaxosmithkline (Ireland) Limited

BlenrepEuropean Union · GlaxoSmithKline Trading Services Limited

BlenrepCroatia

BlenrepItaly · Polvere per concentrato per soluzione per infusione · Glaxosmithkline Trading Services Limited

BlenrepUnited States · 70MG · injectable · Glaxosmithkline LLC

BlenrepUnited States · 100MG · For Injection · GlaxoSmithKline Intellectual Property Development Ltd. England

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Belantamab mafodotin
Dosage form: Poeder voor concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 23 Jul 2025
Registration: EU/1/25/1948
Marketing authorisation holder: GlaxoSmithKline Trading Services Limited
ATC code: L01FX15
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/006511
EU number: EU/1/25/1948